Target gene ID'd in bone marrow disease
Posted on: Wednesday, 30 September 2009, 07:54 CDT
U.S. medical geneticists say they have identified a possible new target gene for treatment of myelodysplastic syndrome, a bone marrow disease.
Van Andel Research Institute scientists in Grand Rapids, Mich., said their findings move science one step closer to finding new ways to treat the disease that sometimes leads to acute myeloid leukemia.
Researchers said they found the gene RhoB is important to the disease's progression and could prove to be a therapeutic target for late-stage myelodysplastic syndrome.
Using our genetic models, we've been able to provide a better understanding of underlying molecular defects that drive the malignant progression of (the disease),
said Art Alberts, who led the research. The genes that we've focused on in this study might have a role not only in leukemia, but in solid tumors as well.
The research was recently reported in the online journal PLoS One.
Source: United Press International
Related Articles
- 3M Collaborates With Infectious Disease Research Institute on Vaccine Adjuvants
- Infectious Disease Research Institute Receives Grant From the Bill & Melinda Gates Foundation for Adjuvant Access and Development
- Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment From M.J. Murdock Charitable Trust
- Infectious Disease Research Institute and Chembio to Develop Tests for Leishmaniasis and Leprosy
- Chembio and Infectious Disease Research Institute Collaborating on Development of Rapid Tests for Leishmaniasis and Leprosy
- Video: Alzheimer's Disease Research Grants Two $1 Million Centennial Awards
- National Disease Research Interchange Appoints Broxmeyer Board Chairman
- National Disease Research Interchange Receives Funding Commitment for Rare Disease Initiative
- Faster method to create antibodies for disease research
- U-M Health System Receives $10M Grant for Alzheimer's Disease Research
 |
 |
User Comments (0)
RSS Feeds